• BioInvent will hold an extraordinary general meeting in Lund, Sweden, on December 1, 2026, to consider a rights issue.
• Shareholders will vote on the share issue, with its maximum size and subscription price to be set by November 27, 2026.
• The proposed subscription period runs December 7–21, 2026, with December 3, 2026, as the record date for preferential rights.
• Four alternative amendments to share capital and share count limits are proposed; registration will depend on the issue outcome.
• Other proposals include electing Dharminder Chahal, expanding the board to seven members and retaining existing per-member fees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioInvent International AB published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.